CU06-1004 suppresses fibrosis in mice with mild CDAA-induced NASH mice, as evidenced by decreased staining with Sirius red and α-SMA as well as decreased expression of pro-fibrotic genes such as Col1α, Col4α, and TGF-β. This evidence concerns the gene TGFB1 and metabolic dysfunction-associated steatohepatitis.